Skip navigation
Search
Sciety application settings
Home
Groups
Explore
Newsletter
About
Log In
Sign Up
Dynamic ctDNA tracking stratifies relapse risk for triple negative breast cancer patients receiving neoadjuvant chemotherapy
Shunying Li
Yudong Li
Wei Wei
Chang Gong
Ting Wang
Guangxin Li
Feng Yao
Jiang-Hua Ou
Yan Xu
Wei Wu
Liang Jin
Nanyan Rao
Yan Nie
Fengyan Yu
Weijuan Jia
Xing-Rui Li
Jun Zhang
Hua-Wei Yang
Yaping Yang
Mengzi Wu
Qin Li
Fang Li
Yuhua Gong
Xin Yi
Qiang Liu
Read the full article
See related articles
Listed in
This article is not in any list yet, why not save it to one of your lists.
Log in to save this article
Abstract
No abstract available
Article activity feed
Version published to 10.1038/s41467-025-57988-z
Mar 21, 2025
Version published to 10.21203/rs.3.rs-4480804/v1 on Research Square
Jul 10, 2024
Related articles
Clinical Validation of Digital PCR-based ctDNA detection for risk stratification in residual triple negative breast cancer: TRICIA trial results
This article has 18 authors:
Talia Roseshter
Anna Klemantovich
Josiane Lafleur
Cathy Lan
Luca Cavallone
Kathryn Bozek
Juliet Guay
Oluwadara Elebute
Sarah Jenna
Rodney Ouellette
Suzan McNamara
Jean-Francois Boileau
Manuela Pelmus
Muriel Brackstone
Rossanna Pezo
Terry Ng
Adriana Aguilar-Mahecha
Mark Basik
Integrated CT-derived radiomics for predicting ctDNA status and prognosis in resectable non-small cell lung cancer
This article has 14 authors:
Zetian Gong
Yaolin Cao
Xiaoxuan Wang
Hongya Wang
Jie Xu
Hongshun Wang
Xiao Zhang
Hui Gong
Jiatao Liu
Jinpeng Yang
Wenyu Wang
Jun Li
Jianwei Tang
Wei Wang
Neoadjuvant Chemotherapy in early-stage breast cancer: the trend over time and the impact on axillary management, A National Cancer Database Analysis
This article has 6 authors:
Mahtab Vasigh
David Euhus
Fabian M Johnston
Fasika M Abreha
Lisa Jacobs
Olutayo Sogunro
Site navigation links
Home
Groups
Explore
Newsletter
About
Log In
Sign Up